PBT Share Price

Open 0.05 Change Price %
High 0.05 1 Day -0.01 -16.67
Low 0.05 1 Week 0.00 0.00
Close 0.05 1 Month -0.01 -16.67
Volume 34102 1 Year -0.06 -54.55
52 Week High 0.12
52 Week Low 0.04
PBT Important Levels
Resistance 2 0.05
Resistance 1 0.05
Pivot 0.05
Support 1 0.05
Support 2 0.05
ASX Australia Most Active Stocks
LYC 0.15 7.14%
TLS 3.90 0.78%
TLS 3.90 0.78%
TLS 3.90 0.78%
PCL 0.00 0.00%
PCL 0.00 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
VKA 0.02 100.00%
CAV 0.02 100.00%
CAV 0.02 100.00%
GMD 0.02 100.00%
GMD 0.02 100.00%
RDS 0.02 100.00%
RDS 0.02 100.00%
RDS 0.02 100.00%
AZZ 0.50 78.57%
More..
ASX Australia Top Losers Stocks
NME 0.00 -100.00%
NME 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
AZS 0.01 -50.00%
AZS 0.01 -50.00%
More..

Prana Biotechnology Ltd (ASX: PBT)

PBT Technical Analysis 5
As on 18th Aug 2017 PBT Share Price closed @ 0.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.07 & Strong Sell for SHORT-TERM with Stoploss of 0.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
PBT Target for August
1st Target up-side 0.07
2nd Target up-side 0.07
3rd Target up-side 0.07
1st Target down-side 0.05
2nd Target down-side 0.05
3rd Target down-side 0.05
PBT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.pranabio.com
PBT Address
PBT
369 Royal Parade
Level 2
Parkville, VIC 3052
Australia
Phone: 61 3 9349 4906
Fax: 61 3 9348 0377
PBT Latest News
Shares of Prana Biotechnology Limited (NASDAQ:PRAN) Getting a Second Look From ...   Nelson Research   - 18th Aug 17
Prana Biotechnology Limited (PRAN) is at $2.46 per share and Electromed, Inc ...   Stocks Gallery   - 17th Aug 17
Prana Biotechnology Limited (PRAN) noted a price change of -9.06% and WAVE ...   Stocks Gallery   - 16th Aug 17
Prana Biotechnology joins with Takeda to investigate lead drug   Proactive Investors Australia   - 18th Jul 17
Prana Biotech +15% on favorable PBT434 pre-clinical results   Seeking Alpha   - 03rd Jul 17
Why did Prana Biotechnology Limited skyrocket 56% today?   Motley Fool Australia   - 09th Aug 16
Prana Biotechnology Limited soars on positive news: Is it a spec buy?   Motley Fool Australia   - 01st Jun 15
Prana Biotechnology Limited shares crash on trial results   The Motley Fool   - 01st Apr 14
Prana Biotechnology Ltd. ADR   Wall Street Journal   - 11th Feb 11
2.46   MarketWatch   - 17th Nov 10
Interactive Technical Analysis Chart Prana Biotechnology Ltd ( PBT ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Prana Biotechnology Ltd
PBT Business Profile
Prana Biotechnology Limited researches and develops therapeutic drugs for the treatment of neurological disorders in Australia. It primarily focuses on the Alzheimer‘s, Parkinson‘s, and Huntington‘s diseases, as well as various cancer and age-related macular degeneration. The company’s product line includes PBT2, which is in Phase IIb clinical trials for the treatment of Alzheimer’s disease, as well as in Phase IIa clinical trials to treat Huntington’s disease. Its preclinical products comprise PBT434 for the treatment of Alzheimer’s disease; and PBT519 to treat brain cancer. The company was formerly known as Prana Corporation Ltd. and changed its name to Prana Biotechnology Limited in January 2000. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.